Trinity Capital Inc.
TRIN NYSE Financials FY2020βFY2025
What Trinity Capital Inc. does
No business description yet.
- Legal name
- Trinity Capital Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 25, 2026
- Accession Β· CIK
- 0001193125-26-068600
0001786108
Revenue and margins
Trinity Capital Inc. had $4.9M of revenue in fiscal 2025, down 46.2% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Trinity Capital Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 22.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Trinity Capital Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $31.7M | $10.6M | $4.8M | $9.6M | $19.1M |
| Debt incl. finance leases | $466M | $620M | $646M | $888M | $1.3B |
| Debt / equity | 1.0x | 1.3x | 1.1x | 1.1x | 1.2x |
| Total assets | $937M | $1.1B | $1.3B | $1.8B | $2.5B |
| Total liabilities | $491M | $667M | $700M | $951M | $1.4B |
| Shareholders' equity | $447M | $460M | $611M | $823M | $1.1B |
| Net debt (β = net cash) | $434M | $609M | $641M | $878M | $1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | β / 4 | 1 / 7 | 4 / 7 | 2 / 7 | 1 / 7 |
| Accruals ratio | β | 39.9% | 19.9% | 14.2% | 28.0% | 31.5% |
| Altman Z'' | β | β | β | β | β | β |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | β | $0.2M | $0.3M | $8.0M | $9.1M | $4.9M |
| Net interest income | β | $0.2M | $0.3M | $8.0M | $9.1M | $4.9M |
| Net income | β$6.1M | $132M | β$30.4M | $76.9M | $116M | $136M |
| Net income to common | β | $132M | β$30.4M | $76.9M | $116M | $136M |
| Diluted EPS | β$0.34 | $4.64 | β$0.96 | $1.89 | $2.10 | $1.96 |
| Diluted shares | 0.02B | 0.03B | 0.04B | 0.04B | 0.06B | 0.07B |
| Cash flow | ||||||
| Cash from operations | β$58.2M | β$242M | β$236M | β$96.3M | β$317M | β$535M |
| Stock-based compensation | β | $1.1M | $6.1M | $8.8M | $10.5M | $12.0M |
| Balance sheet | ||||||
| Cash and short-term investments | $44.7M | $31.7M | $10.6M | $4.8M | $9.6M | $19.1M |
| Total debt | $310M | $466M | $620M | $646M | $888M | $1.3B |
| Deposits | β | $10.8M | $15.1M | $12.3M | $8.5M | $3.0M |
| Total assets | β | $937M | $1.1B | $1.3B | $1.8B | $2.5B |
| Total liabilities | β | $491M | $667M | $700M | $951M | $1.4B |
| Shareholders' equity | β | $447M | $460M | $611M | $823M | $1.1B |
| Margins | ||||||
| Net margin | β | 66,160.0% | β10,125.0% | 961.2% | 1,270.3% | 2,767.4% |
| Net interest share of revenue | β | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Returns | ||||||
| Return on equity | β | 29.6% | β6.7% | 14.4% | 16.1% | 14.1% |
| Return on assets | β | 14.1% | β2.9% | 6.3% | 7.5% | 6.4% |
| Return on tangible equity | β | 29.6% | β6.6% | 12.6% | 14.0% | 12.4% |
| Growth | ||||||
| Revenue growth | β | β | 50.0% | 2,566.7% | 13.8% | β46.2% |
| Net income growth | β | β | β123.0% | β | 50.3% | 17.3% |
| EPS growth | β | β | β120.7% | β | 11.1% | β6.7% |
| Share count change | β | 62.1% | 20.0% | 21.4% | 32.8% | 22.1% |
| Financial health | ||||||
| Debt / equity | β | 1.0x | 1.3x | 1.1x | 1.1x | 1.2x |
| Capital allocation | ||||||
| Stock comp / revenue | β | 533.0% | 2,020.7% | 110.0% | 115.9% | 245.9% |
| Quality scores | ||||||
| Piotroski F-score | β | β | 1.0 | 4.0 | 2.0 | 1.0 |
| Accruals ratio | β | 39.9% | 19.9% | 14.2% | 28.0% | 31.5% |
Source: SEC EDGAR XBRL filings (CIK 0001786108). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.